ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2988

Calgranulin Levels Are Elevated in Spondyloarthritis and Reflect the Presence of Acute Microscopic Gut Inflammation

Heleen Cypers1, Gaëlle Varkas1, Liesbet Van Praet1, Johannes Roth2, Thomas Vogl2, Claude Cuvelier3, Dirk Föll4, Miha Lavric5, Filip van Den Bosch1 and Dirk Elewaut1, 1Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium, 2Immunology, Institute of Immunology University of Muenster, Muenster, Germany, 3Pathology, Department of Pathology Ghent University Hospital, Ghent, Belgium, 4Pediatric Rheumatology and Immunology, University Children's Hospital Muenster, Muenster, Germany, 5University Children's Hospital Muenster, Muenster, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Bowel, innate immunity and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis VI - Imaging and Biomarkers

Session Type: Abstract Submissions (ACR)

Background/Purpose: Microscopic gut inflammation is present in about 50% of spondyloarthritis (SpA) patients. Two types can be distinguished: an acute type resembling infectious enterocolitis, and a chronic type similar to early Crohn’s disease. Although subclinical, microscopic gut inflammation appears to be a prognostic factor in SpA, linked with more extensive disease and a less favorable outcome. At this moment, however, reliable biomarkers are missing. The calgranulins S100A8/S100A9 and S100A12 are very sensitive markers of innate immune activation. They are released from monocytes and granulocytes in the early phase of the immune response and exert important pro-inflammatory effects via Toll-like receptor 4 dependent mechanisms. Calgranulins can be measured in serum and stool. Moreover, the S100A8/S100A9 heterodimer, also called calprotectin, has been established for a long time as a fecal marker of disease activity in inflammatory bowel disease. Our aim was to  assess whether calgranulins can be used as biomarkers for microscopic gut inflammation in SpA.

Methods: Serum levels of calgranulins were measured in 103 newly diagnosed SpA patients and 24 healthy controls. Ninety seven SpA patients underwent an ileocolonoscopy to assess the presence of microscopic gut inflammation. Ileal and colonic biopsies were histologically scored and subsequently immuno-stained for S100A8 and S100A9.

Results and Conclusion: Serum levels of S100A8/S100A9 and S100A12 were significantly higher in SpA patients versus healthy controls (p= 0,035 and p = 0,024). Levels correlated moderately with CRP, but not with ASDAS, BASDAI or swollen joint count. SpA patients with the acute type of microscopic gut inflammation (N= 17) had significantly higher calgranulin levels compared to those with normal gut histology (N= 56) (p = 0,021 for S100A8/S100A9 and p = 0,05 for S100A12). Furthermore, immunohistology showed high staining of S100A8 and S100A9 on acutely inflamed gut biopsies, compared to absent/minimal staining on normal biopsies. Chronically inflamed biopsies (N=24) stained positive only when they had high inflammatory activity (in ~ 50% of cases). Importantly, NSAID intake had neither influence on immunohistology stainings nor on serum levels of calgranulins. To conclude, we found that calgranulin levels, both systemically and locally, marked the presence of acute microscopic gut inflammation in SpA. These results illustrate their high sensitivity as they reflected inflammation present only on a subclinical level. Therefore we anticipate that they may be of particular value in detecting (or excluding) latent (systemic) disease.

Acknowledgements: The research leading to these results has received funding from the European Union’s 7th Framework Program under EC-GA No.  305266  “MIAMI”.


Disclosure:

H. Cypers,
None;

G. Varkas,
None;

L. Van Praet,
None;

J. Roth,
None;

T. Vogl,
None;

C. Cuvelier,
None;

D. Föll,
None;

M. Lavric,
None;

F. van Den Bosch,
None;

D. Elewaut,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/calgranulin-levels-are-elevated-in-spondyloarthritis-and-reflect-the-presence-of-acute-microscopic-gut-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology